Provided by Tiger Trade Technology Pte. Ltd.

Lipella Pharmaceuticals Inc

0.0723
-0.0698-49.12%
Volume:138.11K
Turnover:12.51K
Market Cap:322.99K
PE:-0.03
High:0.1210
Open:0.1210
Low:0.0723
Close:0.1421
52wk High:3.17
52wk Low:0.0723
Shares:4.47M
Float Shares:4.18M
Volume Ratio:58.21
T/O Rate:3.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2600
EPS(LYR):-4.7857
ROE:-361.77%
ROA:-149.95%
PB:0.22
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
Lipella Pharmaceuticals Inc
Exchange:
PINK
Establishment Date:
2005
Employees:
6
Office Location:
7800 Susquehanna St.,Suite 505,Pittsburgh,Pennsylvania,United States
Zip Code:
15208
Fax:
- -
Introduction:
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.